D
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Price:
19.07
CNY
-0.68%
Market Closed
Market Cap:
¥21.7B
Income Statement
Earnings Waterfall
DaShenLin Pharmaceutical Group Co Ltd
DaShenLin Pharmaceutical Group Co Ltd
Income Statement
DaShenLin Pharmaceutical Group Co Ltd
DaShenLin Pharmaceutical Group Co Ltd
Currency: CNY
| Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||
| Interest Expense |
13
|
0
|
0
|
0
|
18
|
5
|
12
|
19
|
24
|
23
|
29
|
27
|
32
|
29
|
17
|
13
|
11
|
60
|
101
|
160
|
212
|
159
|
180
|
179
|
232
|
182
|
179
|
182
|
239
|
184
|
185
|
176
|
249
|
166
|
0
|
0
|
|
| Revenue |
6 274
N/A
|
6 545
+4%
|
6 824
+4%
|
6 992
+2%
|
7 421
+6%
|
7 718
+4%
|
8 003
+4%
|
8 421
+5%
|
8 859
+5%
|
9 404
+6%
|
10 029
+7%
|
10 601
+6%
|
11 141
+5%
|
11 925
+7%
|
12 829
+8%
|
13 593
+6%
|
14 583
+7%
|
15 280
+5%
|
15 697
+3%
|
16 446
+5%
|
16 759
+2%
|
17 377
+4%
|
18 425
+6%
|
19 222
+4%
|
21 248
+11%
|
22 518
+6%
|
23 519
+4%
|
24 154
+3%
|
24 531
+2%
|
25 336
+3%
|
25 885
+2%
|
26 539
+3%
|
26 497
0%
|
26 701
+1%
|
26 674
0%
|
26 834
+1%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(3 755)
|
(3 970)
|
(4 131)
|
(4 192)
|
(4 443)
|
(4 636)
|
(4 764)
|
(4 999)
|
(5 176)
|
(5 581)
|
(6 003)
|
(6 398)
|
(6 752)
|
(7 334)
|
(7 949)
|
(8 408)
|
(8 993)
|
(9 405)
|
(9 641)
|
(10 223)
|
(10 385)
|
(10 710)
|
(11 411)
|
(11 884)
|
(13 226)
|
(14 243)
|
(14 926)
|
(15 387)
|
(15 795)
|
(16 503)
|
(17 016)
|
(17 570)
|
(17 422)
|
(17 687)
|
(17 641)
|
(17 717)
|
|
| Gross Profit |
2 519
N/A
|
2 575
+2%
|
2 693
+5%
|
2 800
+4%
|
2 979
+6%
|
3 083
+3%
|
3 239
+5%
|
3 422
+6%
|
3 683
+8%
|
3 823
+4%
|
4 026
+5%
|
4 203
+4%
|
4 389
+4%
|
4 591
+5%
|
4 880
+6%
|
5 185
+6%
|
5 590
+8%
|
5 875
+5%
|
6 056
+3%
|
6 222
+3%
|
6 374
+2%
|
6 667
+5%
|
7 014
+5%
|
7 338
+5%
|
8 022
+9%
|
8 275
+3%
|
8 593
+4%
|
8 767
+2%
|
8 736
0%
|
8 834
+1%
|
8 869
+0%
|
8 969
+1%
|
9 074
+1%
|
9 014
-1%
|
9 033
+0%
|
9 117
+1%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(1 932)
|
(1 962)
|
(2 051)
|
(2 152)
|
(2 341)
|
(2 399)
|
(2 547)
|
(2 715)
|
(2 968)
|
(3 042)
|
(3 163)
|
(3 281)
|
(3 479)
|
(3 525)
|
(3 661)
|
(3 843)
|
(4 199)
|
(4 359)
|
(4 599)
|
(4 856)
|
(5 239)
|
(5 415)
|
(5 652)
|
(5 901)
|
(6 438)
|
(6 498)
|
(6 696)
|
(6 792)
|
(6 959)
|
(7 128)
|
(7 364)
|
(7 568)
|
(7 545)
|
(7 428)
|
(7 327)
|
(7 288)
|
|
| Selling, General & Administrative |
(1 797)
|
(1 955)
|
(2 045)
|
(2 147)
|
(2 170)
|
(2 388)
|
(2 535)
|
(2 705)
|
(2 741)
|
(3 048)
|
(3 167)
|
(3 287)
|
(3 211)
|
(3 562)
|
(3 694)
|
(3 881)
|
(3 930)
|
(4 414)
|
(4 654)
|
(4 916)
|
(4 902)
|
(5 433)
|
(5 708)
|
(5 926)
|
(5 956)
|
(6 443)
|
(6 619)
|
(6 729)
|
(6 474)
|
(7 091)
|
(7 323)
|
(7 536)
|
(7 025)
|
(7 432)
|
(7 338)
|
(7 265)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
0
|
(1)
|
(1)
|
(1)
|
(4)
|
(6)
|
(10)
|
(13)
|
(43)
|
(51)
|
(56)
|
(71)
|
(72)
|
(80)
|
(80)
|
(75)
|
(76)
|
(79)
|
(86)
|
(93)
|
(49)
|
(48)
|
(51)
|
(49)
|
|
| Depreciation & Amortization |
(116)
|
0
|
0
|
0
|
(159)
|
0
|
0
|
0
|
(227)
|
0
|
0
|
0
|
(273)
|
0
|
0
|
0
|
(312)
|
0
|
0
|
0
|
(369)
|
0
|
0
|
0
|
(430)
|
0
|
0
|
0
|
(463)
|
0
|
0
|
0
|
(549)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(20)
|
(7)
|
(6)
|
(5)
|
(12)
|
(11)
|
(11)
|
(10)
|
0
|
7
|
5
|
8
|
6
|
38
|
34
|
39
|
48
|
61
|
65
|
74
|
74
|
69
|
112
|
96
|
19
|
25
|
3
|
12
|
54
|
41
|
45
|
61
|
78
|
51
|
62
|
26
|
|
| Operating Income |
586
N/A
|
613
+5%
|
642
+5%
|
648
+1%
|
637
-2%
|
684
+7%
|
693
+1%
|
707
+2%
|
715
+1%
|
781
+9%
|
862
+10%
|
923
+7%
|
910
-1%
|
1 066
+17%
|
1 219
+14%
|
1 342
+10%
|
1 391
+4%
|
1 516
+9%
|
1 457
-4%
|
1 367
-6%
|
1 135
-17%
|
1 252
+10%
|
1 362
+9%
|
1 437
+6%
|
1 584
+10%
|
1 777
+12%
|
1 897
+7%
|
1 974
+4%
|
1 778
-10%
|
1 706
-4%
|
1 504
-12%
|
1 402
-7%
|
1 529
+9%
|
1 585
+4%
|
1 705
+8%
|
1 828
+7%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(8)
|
(27)
|
(28)
|
(27)
|
(3)
|
(13)
|
(8)
|
(10)
|
4
|
(13)
|
(15)
|
(11)
|
10
|
(3)
|
9
|
21
|
64
|
3
|
32
|
(21)
|
(100)
|
(183)
|
(253)
|
(262)
|
(182)
|
(183)
|
(193)
|
(187)
|
(143)
|
(188)
|
(196)
|
(196)
|
(156)
|
(171)
|
(157)
|
(146)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(7)
|
(3)
|
(1)
|
(2)
|
6
|
7
|
6
|
7
|
18
|
18
|
19
|
14
|
(3)
|
1
|
(4)
|
8
|
(19)
|
19
|
26
|
21
|
|
| Gain/Loss on Disposition of Assets |
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
(2)
|
2
|
(0)
|
1
|
2
|
3
|
5
|
1
|
2
|
3
|
5
|
1
|
1
|
(3)
|
(8)
|
(2)
|
(1)
|
(5)
|
(3)
|
3
|
4
|
13
|
10
|
(6)
|
(12)
|
(18)
|
(23)
|
(4)
|
2
|
(2)
|
3
|
(15)
|
(16)
|
(12)
|
(21)
|
|
| Pre-Tax Income |
577
N/A
|
584
+1%
|
615
+5%
|
621
+1%
|
635
+2%
|
672
+6%
|
686
+2%
|
700
+2%
|
720
+3%
|
770
+7%
|
849
+10%
|
915
+8%
|
919
+0%
|
1 062
+16%
|
1 224
+15%
|
1 354
+11%
|
1 446
+7%
|
1 514
+5%
|
1 482
-2%
|
1 340
-10%
|
1 044
-22%
|
1 080
+3%
|
1 128
+4%
|
1 191
+6%
|
1 415
+19%
|
1 600
+13%
|
1 704
+6%
|
1 779
+4%
|
1 628
-9%
|
1 520
-7%
|
1 302
-14%
|
1 217
-7%
|
1 340
+10%
|
1 417
+6%
|
1 563
+10%
|
1 683
+8%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||
| Tax Provision |
(149)
|
(153)
|
(160)
|
(161)
|
(160)
|
(169)
|
(174)
|
(182)
|
(194)
|
(207)
|
(229)
|
(247)
|
(223)
|
(264)
|
(301)
|
(329)
|
(363)
|
(368)
|
(349)
|
(309)
|
(240)
|
(240)
|
(267)
|
(291)
|
(336)
|
(380)
|
(384)
|
(403)
|
(397)
|
(360)
|
(324)
|
(295)
|
(360)
|
(393)
|
(427)
|
(457)
|
|
| Income from Continuing Operations |
429
|
431
|
456
|
460
|
475
|
503
|
512
|
518
|
526
|
563
|
620
|
668
|
697
|
798
|
923
|
1 026
|
1 083
|
1 146
|
1 134
|
1 031
|
804
|
840
|
861
|
901
|
1 079
|
1 220
|
1 320
|
1 377
|
1 231
|
1 160
|
978
|
922
|
980
|
1 024
|
1 136
|
1 226
|
|
| Income to Minority Interest |
2
|
2
|
2
|
2
|
0
|
2
|
3
|
4
|
6
|
6
|
5
|
6
|
6
|
0
|
(6)
|
(12)
|
(21)
|
(24)
|
(21)
|
(18)
|
(13)
|
(5)
|
(1)
|
(5)
|
(44)
|
(72)
|
(81)
|
(90)
|
(64)
|
(92)
|
(71)
|
(72)
|
(65)
|
(48)
|
(81)
|
(88)
|
|
| Net Income (Common) |
430
N/A
|
433
+1%
|
458
+6%
|
462
+1%
|
475
+3%
|
505
+6%
|
515
+2%
|
522
+1%
|
532
+2%
|
569
+7%
|
624
+10%
|
674
+8%
|
703
+4%
|
799
+14%
|
917
+15%
|
1 014
+11%
|
1 062
+5%
|
1 123
+6%
|
1 113
-1%
|
1 013
-9%
|
791
-22%
|
835
+6%
|
860
+3%
|
896
+4%
|
1 036
+16%
|
1 148
+11%
|
1 239
+8%
|
1 287
+4%
|
1 166
-9%
|
1 068
-8%
|
907
-15%
|
850
-6%
|
915
+8%
|
976
+7%
|
1 055
+8%
|
1 138
+8%
|
|
| EPS (Diluted) |
0.64
N/A
|
0.64
N/A
|
0.67
+5%
|
0.61
-9%
|
0.67
+10%
|
0.67
N/A
|
0.7
+4%
|
0.68
-3%
|
0.71
+4%
|
0.77
+8%
|
0.84
+9%
|
0.9
+7%
|
0.87
-3%
|
1.01
+16%
|
1.18
+17%
|
1.3
+10%
|
1.35
+4%
|
1.43
+6%
|
1.16
-19%
|
0.88
-24%
|
0.69
-22%
|
0.87
+26%
|
0.89
+2%
|
0.78
-12%
|
0.91
+17%
|
1
+10%
|
1.09
+9%
|
1.13
+4%
|
1.03
-9%
|
0.94
-9%
|
0.79
-16%
|
0.74
-6%
|
0.81
+9%
|
0.85
+5%
|
0.92
+8%
|
1
+9%
|
|
Switch to:
Switch to:
See Also
Discover More
